US Stock MarketDetailed Quotes

TTOO T2 Biosystems

Watchlist
  • 0.061
  • -0.004-6.35%
15min DelayClose Feb 14 16:00 ET
1.71MMarket Cap-2.04P/E (TTM)

About T2 Biosystems Company

T2 Biosystems, Inc. is a vitro diagnostics company, which engages in the development of detection of sepsis-causing pathogens. It offers T2Dx instrument, T2Bacteria, T2Candida, T2Biothreat panels, and T2MR technology. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.

Company Profile

SymbolTTOO
Company NameT2 Biosystems
Listing DateAug 7, 2014
Issue Price11.00
Founded2006
CEOMr. John J. Sperzel, III
MarketPink Market
Employees113
Fiscal Year Ends12-31
Address101 Hartwell Avenue
CityLexington
ProvinceMassachusetts
CountryUnited States of America
Zip Code02421
Phone1-781-761-4646

Company Executives

  • Name
  • Position
  • Salary
  • John J. Sperzel, III
  • Chairman of the Board, Chief Executive Officer and President
  • 865.50K
  • John M. Sprague
  • Chief Financial Officer and Principal Accounting Officer
  • 581.00K
  • Brett A. Giffin
  • Chief Commercial Officer
  • --
  • Roger Smith, PhD
  • Senior Vice President, Science Research and Development
  • --
  • Michael Terrence Gibbs, Esq.
  • Senior Vice President and General Counsel
  • 622.60K
  • Dr. Ninfa M. Saunders
  • Independent Director
  • 50.00K
  • Laura Adams
  • Independent Director
  • 40.00K
  • David B. Elsbree
  • Independent Director
  • 60.00K
  • Robin Toft
  • Independent Director
  • 60.00K
  • Seymour E. Liebman
  • Independent Director
  • 40.00K
  • John W. Cumming
  • Lead Independent Director
  • 96.00K

Trending Stocks

Discussing
Tesla's earnings caused fluctuations, what's your market outlook?
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More